机译:HMGA1中的低频变异与2型糖尿病风险无关
UMR CNRS 8199, Genomic and Metabolic Disease, Lille, France;
UMR CNRS 8199, Genomic and Metabolic Disease, Lille, France;
Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, U.K,Genetics of Complex Traits, Peninsula Medical School, University of Exeter, Exeter, U.K.;
Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, U.K.;
Genomic Medicine, Hammersmith Hospital,Imperial College London, London, U.K.;
Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, U.K.;
UMR CNRS 8199, Genomic and Metabolic Disease, Lille, France;
UMR CNRS 8199, Genomic and Metabolic Disease, Lille, France;
UMR CNRS 8199, Genomic and Metabolic Disease, Lille, France;
UMR CNRS 8199, Genomic and Metabolic Disease, Lille, France;
Cell Therapy of Diabetes, INSERM 859, Lille, France;
UMR CNRS 8199, Genomic and Metabolic Disease, Lille, France;
Corbeil-Essonnes Hospital, Department of Endocrinology-Diabetology, Corbeil-Essonnes, France;
Department of Molecular and Clinical Medicine and Center for Cardiovascular and Metabolic Research, The Sahlgrenska Academy, Gothenburg, Sweden;
Department of Molecular and Clinical Medicine and Center for Cardiovascular and Metabolic Research, The Sahlgrenska Academy, Gothenburg, Sweden;
Department of Molecular and Clinical Medicine and Center for Cardiovascular and Metabolic Research, The Sahlgrenska Academy, Gothenburg, Sweden;
Institut inter Regional pour la SAnte, La Riche, France;
NSERM Centre de recherche en Epidemiologie et Sante des Populations U1018, Villejuif, France;
Genomic Medicine, Hammersmith Hospital,Imperial College London, London, U.K.;
NSERM Centre de recherche en Epidemiologie et Sante des Populations U1018, Villejuif, France;
UMR CNRS 8199, Genomic and Metabolic Disease, Lille, France;
UMR CNRS 8199, Genomic and Metabolic Disease, Lille, France,Genomic Medicine, Hammersmith Hospital,Imperial College London, London, U.K.;
UMR CNRS 8199, Genomic and Metabolic Disease, Lille, France;
机译:鉴定与2型糖尿病风险升高或降低相关的低频和罕见序列变异。
机译:常见和低频WFS1变异在2型糖尿病风险中的作用的详细调查
机译:常见和低频WFS1变异在2型糖尿病风险中的作用的详细调查
机译:使用常见和罕见遗传变异进行风险预测:应用于2型糖尿病
机译:建立2型糖尿病的大众传播健康交流策略的方法:检查拉丁裔和非拉丁裔白人大学生对2型糖尿病风险的认识。
机译:评论:Marquez等。 HMGA1中的低频变异与2型糖尿病风险无关。糖尿病2012; 61:524–530
机译:HMGA1中的低频变异与2型糖尿病风险无关。